Skip to content
Search

Latest Stories

Pakistan central bank holds interest rates ahead of polls next week

The governor of the State Bank of Pakistan (SBP) said the decision was warranted due to “elevated� inflation – which was 29.7 per cent in December

Pakistan central bank holds interest rates ahead of polls next week

PAKISTAN’S central bank on Monday (29) held its key rate at 22 per cent for the fifth policy meeting in a row and increased its full-year inflation projections.

The governor of the State Bank of Pakistan (SBP) said the decision was warranted due to “elevated” inflation – which was 29.7 per cent in December.


He said that a rise in the bank’s average inflation forecast for the fiscal year ending in June to 23 per cent to 25 per cent, from a previous projection of 20 per cent to 22 per cent, was due to the rising prices of gas and electricity in the country.

The decision is the last under a caretaker government before general elections due next week and comes as Pakistan undertakes reforms linked to a $3 billion (£2.37bn) Standby Arrangement with the International Monetary Fund (IMF).

“SBP opted for a wait and see approach during this policy (meeting) and refrained from abruptly starting a monetary easing cycle,” said Tahir Abbas, head of research at Arif Habib Limited.

“Economic indicators are gradually improving and inflation is expected to decline significantly from March 2024 onwards, where we believe that (the) SBP is expected to start a monetary easing cycle,” he said.

The country’s external accounts and foreign exchange reserves have improved, the current account deficit is expected to shrink, the central bank’s governor Jameel Ahmad said.

Pakistan’s key rate was raised to an all-time high of 22 per cent in June to fight persistent inflationary pressures and to meet one of the conditions set by the IMF for securing the bailout.

While the rescue programme has helped avert a sovereign debt default, some of the attached conditions, such as raising its benchmark interest rate, increasing government revenue, and increasing electricity and natural gas prices, have complicated efforts to curb inflation and dampened sentiment. But Ahmad said Pakistan was in a “better position” since signing the stand-by agreement.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less